Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: Sharck who wrote (31062)	7/16/2001 7:55:14 AM
From: canmar	Read Replies (1) \| Respond to of 37746

This could be interesting for today: MONROVIA, Calif., July 16 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA) announced today that it has received Pre-Market Approval (PMA) from the United States Food and Drug Administration (FDA) for its AquaFlow(TM) Collagen Glaucoma Drainage Device for use in the correction of open-angle Glaucoma. The Company is prepared to begin shipment of the device immediately. The AquaFlow has been approved and marketed in other countries for several years. In 1997, AquaFlow received CE Mark allowing it to be marketed throughout the European Union. Earlier this year a Medical Device Licensure was received from Health Canada, allowing the marketing of AquaFlow throughout Canada.